These findings are consistent with recent work of Criscuolo et al., who reported that platinum resistance in ovarian cancer cells was associated with downregulation of farnesyl diphosphate synthase and oxidosqualene cyclase, key cholesterol biosynthesis enzymes [81]. Here, FDPS is linked to ovarian cancer.